|
Market Closed -
Bombay S.E.
14:21:09 25/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 2,980.05 INR | +1.69% |
|
+10.38% | +20.60% |
| 08-03 | GSK India first-quarter profit rises on steady vaccine demand | RE |
| 08-03 | GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 505B 5.3B 4.54B 4.25B 3.88B 7.33B 7.4B 50.15B 19.52B 255B 19.88B 19.45B 843B | P/E 2027 * |
43.5x | P/E 2028 * | 37.8x |
|---|---|---|---|---|---|
| Enterprise Value | 505B 5.3B 4.54B 4.25B 3.88B 7.33B 7.4B 50.15B 19.52B 255B 19.88B 19.45B 843B | EV / Sales 2027 * |
11.9x | EV / Sales 2028 * | 10.7x |
| Free-Float |
-
| Yield 2027 * |
0.99% | Yield 2028 * | 0.99% |
Last Transcript: GlaxoSmithKline Pharmaceuticals Limited
| 1 day | +1.69% | ||
| 1 week | +10.38% | ||
| Current month | +12.31% | ||
| 1 month | +18.57% | ||
| 3 months | +29.02% | ||
| 6 months | +13.77% | ||
| Current year | +20.60% |
| 1 week | 2,854.85 |  | 3,051 |
| 1 month | 2,494.7 | | 3,051 |
| Current year | 2,088 | | 3,051 |
| 1 year | 2,088 | | 3,051 |
| 3 years | 1,387.9 | | 3,515.95 |
| 5 years | 1,228 | | 3,515.95 |
| 10 years | 1,020 | | 3,515.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bhushan Akshikar
CEO | Chief Executive Officer | 56 | 01/12/2022 |
Ronojit Biswas
DFI | Director of Finance/CFO | - | 01/04/2026 |
Shalini Menon
CTO | Chief Tech/Sci/R&D Officer | - | 08/07/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Renu Sud Karnad
CHM | Chairman | 73 | 01/04/2019 |
| Director/Board Member | 59 | 18/05/2020 | |
Manu Anand
BRD | Director/Board Member | 67 | 16/05/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.69% | +10.38% | +6.45% | +111.03% | 5.18B | |
| -1.06% | +0.65% | +77.42% | +122.82% | 1,111B | |
| +0.53% | +0.75% | +53.10% | +64.29% | 658B | |
| +0.48% | +2.65% | +28.06% | +81.19% | 467B | |
| +0.92% | +4.97% | +42.94% | +43.69% | 369B | |
| +1.25% | +4.00% | +25.87% | +42.82% | 301B | |
| +3.02% | +7.92% | +4.24% | +16.06% | 256B | |
| -0.36% | +3.99% | +53.31% | +72.49% | 240B | |
| +2.86% | +5.27% | -15.42% | -52.34% | 207B | |
| +1.38% | +3.72% | +30.33% | +93.56% | 182B | |
| Average | +1.12% | +4.90% | +30.63% | +59.56% | 379.62B | |
| Weighted average by Cap. | +0.62% | +4.69% | +45.83% | +72.19% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 42.53B 446M 382M 358M 327M 617M 624M 4.22B 1.64B 21.46B 1.67B 1.64B 71.06B | 47.17B 495M 424M 397M 363M 685M 692M 4.69B 1.82B 23.8B 1.86B 1.82B 78.81B |
| Net income | 11.61B 122M 104M 97.79M 89.33M 169M 170M 1.15B 449M 5.86B 457M 447M 19.4B | 13.36B 140M 120M 113M 103M 194M 196M 1.33B 517M 6.74B 526M 515M 22.33B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/08/26 | ₹2,980.05 | +1.69% | 235,095 |
| 24/08/26 | ₹2,930.50 | +1.07% | 3,455 |
| 21/08/26 | ₹2,899.60 | -3.35% | 6,539 |
| 20/08/26 | ₹2,999.95 | -1.12% | 17,359 |
| 19/08/26 | ₹3,034.05 | +5.23% | 99,093 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLAXO Stock
Select your edition
All financial news and data tailored to specific country editions
